VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Fastenal Company vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Fastenal Company
FAST · Nasdaq Stock Market
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Fastenal Company's moat claims, evidence, and risks.
View FAST analysisPfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Fastenal Company leads (60 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: Fastenal Company has 3 segments (54.5% in Branch-based distribution (in-market branches)); Pfizer Inc. has 5 segments (47.4% in Primary Care).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Weak vs Moderate.
- Moat breadth: Fastenal Company has 5 moat types across 2 domains; Pfizer Inc. has 8 across 3.
Primary market context
Fastenal Company
Branch-based distribution (in-market branches)
Industrial & construction supplies distribution (MRO/OEM consumables) via local branches
North America (primary) + select international
B2B
Distributor / MRO supplier
54.5%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
47.4%
Side-by-side metrics
Moat coverage
Shared moat types
Fastenal Company strengths
Pfizer Inc. strengths
Segment mix
Fastenal Company segments
Full profile >Branch-based distribution (in-market branches)
Competitive
Onsite solutions (embedded customer locations)
Competitive
Other / non-traditional sales (services & custom manufacturing)
Competitive
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Pfizer CentreOne
Competitive
Pfizer Ignite
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.